Zosano Pharma Corp (ZSAN.OQ)
ZSAN.OQ on NASDAQ Stock Exchange Capital Market
3.53USD
14 Dec 2018
3.53USD
14 Dec 2018
Change (% chg)
$-0.10 (-2.75%)
$-0.10 (-2.75%)
Prev Close
$3.63
$3.63
Open
$3.57
$3.57
Day's High
$3.68
$3.68
Day's Low
$3.53
$3.53
Volume
2,605
2,605
Avg. Vol
17,857
17,857
52-wk High
$25.69
$25.69
52-wk Low
$3.30
$3.30
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.00 | -0.682 |
| Jun '18 | 0.00 | -0.752 | |
| Mar '18 | 0.00 | -4.159 | |
| FY 2017 | Dec '17 | 0.00 | -3.799 |
| Sep '17 | 0.00 | -4.014 | |
| Jun '17 | 0.00 | -3.442 | |
| Mar '17 | 0.00 | -6.882 | |
| FY 2016 | Dec '16 | 0.00 | -9.205 |
| Sep '16 | 0.00 | -10.447 | |
| Jun '16 | 0.00 | -10.856 | |
| Mar '16 | 0.00 | -13.562 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-18 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 1 | 1.70 | 1.70 | 1.70 | 3.25 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 1 | -0.69 | -0.69 | -0.69 | -4.20 |
| Year Ending Dec-18 | 1 | -3.55 | -3.55 | -3.55 | -18.00 |
| Year Ending Dec-19 | 1 | -2.12 | -2.12 | -2.12 | -13.20 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.71 | 34.39 | |
| P/E High - Last 5 Yrs. | -- | 148.17 | 46.24 | |
| P/E Low - Last 5 Yrs. | -- | 47.84 | 24.59 | |
| Beta | -- | 1.08 | 0.91 | |
| Price to Sales (TTM) | -- | 49.58 | 6.22 | |
| Price to Book (MRQ) | 1.51 | 10.17 | 5.20 | |
| Price to Tangible Book (MRQ) | 1.52 | 13.83 | 6.74 | |
| Price to Cash Flow (TTM) | -- | 52.85 | 24.17 | |
| % Owned Institutions | 37.79 | 3.75 | 1.78 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.44 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.46 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.94 | |
| Payout Ratio(TTM) | -- | 7.05 | 42.49 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 130.06 | 8.17 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 47.89 | 6.50 | |
| Sales - 5 Yr. Growth Rate | -- | 22.79 | 10.44 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 68.30 | 75.90 | 23.09 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 41.92 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 12.04 | 10.49 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 9.25 | 14.59 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.18 | 2.28 |
| Current Ratio (MRQ) | 3.25 | 3.44 | 3.10 |
| LT Debt to Equity (MRQ) | 16.01 | 18.69 | 11.49 |
| Total Debt to Equity (MRQ) | 43.88 | 31.36 | 16.03 |
| Interest Coverage (TTM) | -23.32 | -43.32 | 30.57 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.37 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.62 | 52.36 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -110.03 | 13.16 | |
| Operating Margin (TTM) | -- | -185.03 | 6.07 | |
| Operating Margin - 5 Yr. Avg. | -- | -126.47 | 8.47 | |
| Pre-Tax Margin (TTM) | -- | -175.80 | 7.02 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -132.63 | 8.71 | |
| Net Profit Margin (TTM) | -- | -182.53 | 3.12 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -137.03 | 4.91 | |
| Effective Tax Rate (TTM) | -- | 21.47 | 23.26 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.43 | 23.83 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 7,648,872 | 873,051,409 | |
| Net Income/Employee (TTM) | -- | 653,324 | 103,483,755 | |
| Receivable Turnover (TTM) | -- | 6.25 | 5.80 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.56 | |
| Asset Turnover (TTM) | 0.00 | 0.32 | 0.95 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -88.63 | 6.47 | 11.45 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.54 | 12.50 | |
| Return on Investment (TTM) | -122.26 | 9.01 | 14.96 | |
| Return on Investment - 5 Yr. Avg. | -- | 6.87 | 16.23 | |
| Return on Equity (TTM) | -167.58 | 10.15 | 16.52 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.40 | 17.37 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -100.00 | -- | -- |
| EPS (TTM) % | 13.03 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Zosano Pharma Corp
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 59.67% |
| # of Holders: | 34 |
| Total Shares Held: | 7,143,839 |
| 3 Mo. Net Change: | -182,815 |
| # New Positions: | 5 |
| # Closed Positions: | 6 |
| # Increased Positions: | 10 |
| # Reduced Positions: | 14 |
| # Net Buyers: | -4 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.